KCNT1 Gene Epilepsy Nocturnal Frontal Lobe Genetic Test
Components: KCNT1 Gene Epilepsy Nocturnal Frontal Lobe Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for KCNT1 Gene Epilepsy, Nocturnal Frontal Lobe NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNT1 Gene Epilepsy, Nocturnal Frontal Lobe.
Test Details
The KCNT1 gene is associated with a rare genetic disorder called epilepsy, nocturnal frontal lobe (ENFL). This disorder is characterized by seizures that occur during sleep and can be difficult to control with medication.
NGS genetic testing (Next Generation Sequencing) can be used to identify mutations in the KCNT1 gene, which can confirm a diagnosis of ENFL. This type of testing involves sequencing the entire gene to identify any changes or mutations that may be causing the disorder.
Identifying the specific mutation in the KCNT1 gene can also help with treatment options and genetic counseling for affected individuals and their families. Treatment for ENFL typically involves anti-seizure medications, but may also include other therapies such as surgery or ketogenic diet.
Overall, NGS genetic testing for the KCNT1 gene can provide important information for the diagnosis and management of ENFL, and may also have implications for other family members who may be at risk for the disorder.
Test Name | KCNT1 Gene Epilepsy nocturnal frontal lobe Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for KCNT1 Gene Epilepsy, nocturnal frontal lobe NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KCNT1 Gene Epilepsy, nocturnal frontal lobe |
Test Details |
The KCNT1 gene is associated with a rare genetic disorder called epilepsy, nocturnal frontal lobe (ENFL). This disorder is characterized by seizures that occur during sleep and can be difficult to control with medication. NGS genetic testing (Next Generation Sequencing) can be used to identify mutations in the KCNT1 gene, which can confirm a diagnosis of ENFL. This type of testing involves sequencing the entire gene to identify any changes or mutations that may be causing the disorder. Identifying the specific mutation in the KCNT1 gene can also help with treatment options and genetic counseling for affected individuals and their families. Treatment for ENFL typically involves anti-seizure medications, but may also include other therapies such as surgery or ketogenic diet. Overall, NGS genetic testing for the KCNT1 gene can provide important information for the diagnosis and management of ENFL, and may also have implications for other family members who may be at risk for the disorder. |